Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125371231 | 12537123 | 1 | I | 20160628 | 20160707 | 20160707 | EXP | KR-JNJFOC-20160701532 | JANSSEN | PARK SH, HWANG SW, KWAK MS, KIM WS, LEE J, LEE H, ET AL. LONG-TERM OUTCOMES OF INFLIXIMAB TREATMENT IN 582 KOREAN PATIENTS WITH CROHN^S DISEASE: A HOSPITAL-BASED COHORT STUDY. DIG DIS SCI 2016;61 (7):2060-2067. | 0.00 | Y | 0.00000 | 20160707 | OT | KR | KR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125371231 | 12537123 | 1 | PS | INFLIXIMAB, RECOMBINANT | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 103772 | 5 | MG/KG | LYOPHILIZED POWDER | |||||||
125371231 | 12537123 | 2 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125371231 | 12537123 | 3 | C | 6-MP | MERCAPTOPURINE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125371231 | 12537123 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125371231 | 12537123 | 1 | Crohn's disease |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125371231 | 12537123 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125371231 | 12537123 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |